Description
BSE lists 1,985,000 new equity shares of Fundviser Capital (India) Limited (Scrip Code 530197) issued on preferential basis via warrant conversion, effective May 14, 2026.
Summary
BSE has listed 1,985,000 new equity shares of Fundviser Capital (India) Limited (Scrip Code: 530197, ISIN: INE365H01014) with effect from May 14, 2026. The shares were issued at Rs. 122.50/- each (face value Rs. 10/- + premium Rs. 112.50/-) to Promoter and Non-Promoter on a preferential basis pursuant to conversion of warrants. These shares rank pari-passu with existing equity shares.
Key Points
- 1,985,000 equity shares of Rs. 10/- each issued at a premium of Rs. 112.50/- (issue price Rs. 122.50/-)
- Allotment date: 23 March 2026
- Distribution numbers: 5,915,001 to 7,900,000
- Shares rank pari-passu with existing equity shares
- Trading permitted on BSE from Thursday, May 14, 2026
- Issued to Promoter and Non-Promoter on preferential basis via warrant conversion
Regulatory Changes
No regulatory changes. This is a standard listing notice for newly issued securities.
Compliance Requirements
Trading members are informed to permit trading of these new securities from May 14, 2026. Lock-in restrictions apply to all allotted shares as detailed below.
Important Dates
- Allotment Date: 23 March 2026
- Trading effective from: 14 May 2026
- Lock-in expiry dates:
- 1,012,000 shares (Dist. Nos. 5,915,001–6,927,000): locked until 30 November 2027
- 138,000 shares (Dist. Nos. 6,927,001–7,065,000): locked until 30 November 2026
- 585,000 shares (Dist. Nos. 7,065,001–7,650,000): locked until 29 November 2026
- 250,000 shares (Dist. Nos. 7,650,001–7,900,000): locked until 30 November 2026
Impact Assessment
The listing adds 1,985,000 new equity shares to the tradeable float of Fundviser Capital (India) Limited, subject to lock-in restrictions. The majority (1,012,000 shares) are locked in until November 2027, limiting immediate selling pressure. Only 835,000 shares become free after November 2026. The issue price of Rs. 122.50/- provides a reference point for market valuation. Impact is confined to existing shareholders and prospective investors in this small-cap scrip.
Impact Justification
Routine listing of new equity shares from preferential allotment via warrant conversion for a small-cap company; limited broader market impact.